Leerink Partners reiterates a Market Perform rating on Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and lowers its price target to $16 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE